Fed Circuit restores two Illumina DNA patents in blow to Roche

The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

Big Pharma

Judge: Roche subsidiaries shouldn’t dodge DNA patent suit

12 August 2021 A Delaware magistrate judge has said that Roche subsidiaries should not be able to dismiss a suit claiming they infringed two DNA patents.

Americas

Roche urges SCOTUS to cancel Illumina patent win

8 January 2021 Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.